| Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis SSM Soliman, C Baldin, Y Gu, S Singh, T Gebremariam, M Swidergall, ... Nature microbiology 6 (3), 313-326, 2021 | 58 | 2021 |
| The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection P Uppuluri, L Lin, A Alqarihi, G Luo, EG Youssef, S Alkhazraji, NY Yount, ... PLoS pathogens 14 (5), e1007056, 2018 | 43 | 2018 |
| Calli essential oils synergize with lawsone against multidrug resistant pathogens SSM Soliman, AI Alsaadi, EG Youssef, G Khitrov, AM Noreddin, ... Molecules 22 (12), 2223, 2017 | 42 | 2017 |
| The combination treatment of fosmanogepix and liposomal amphotericin B is superior to monotherapy in treating experimental invasive mold infections T Gebremariam, Y Gu, S Alkhazraji, E Youssef, KJ Shaw, AS Ibrahim Antimicrobial Agents and Chemotherapy 66 (7), e00380-22, 2022 | 26 | 2022 |
| Monoclonal IgM antibodies targeting Candida albicans Hyr1 provide cross-kingdom protection against Gram-negative bacteria EG Youssef, L Zhang, S Alkhazraji, T Gebremariam, S Singh, NY Yount, ... Frontiers in Immunology 11, 503573, 2020 | 13 | 2020 |
| Tuning sterol extraction kinetics yields a renal-sparing polyene antifungal A Maji, CP Soutar, J Zhang, A Lewandowska, BE Uno, S Yan, Y Shelke, ... Nature 623 (7989), 1079-1085, 2023 | 12 | 2023 |
| Preserving Vascular Integrity Protects Mice Against Multidrug-Resistant Gram-Negative Bacterial Infection ASI Teclegiorgis Gebremariam, Lina Zhang, Sondus Alkhazraji, Yiyou Gu, Eman ... Antimicrobial agents and chemotherapy 64 (8), 2020 | 9 | 2020 |
| Protective Efficacy of Anti-Hyr1p Monoclonal Antibody against Systemic Candidiasis Due to Multi-Drug-Resistant Candida auris S Singh, A Barbarino, EG Youssef, D Coleman, T Gebremariam, ... Journal of Fungi 9 (1), 103, 2023 | 7 | 2023 |
| 119. A Humanized Antibody Targeting the CotH Invasins is Protective Against Murine Mucormycosis Y Gu, A Alqarihi, S Singh, T Gebremariam, S Alkhazraji, E Youssef, ... Open Forum Infectious Diseases 8 (Suppl 1), S71, 2021 | 2 | 2021 |
| LB1580. Efficacy assessment of MAT2203 encochleated oral formulation of amphotericin b, in the neutropenic mouse model of pulmonary mucormycosis T Gebremariam, Y Gu, S Alkhazraji, E Youssef, T Matkovits, J Cobb, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 1890, 2022 | 1 | 2022 |
| Monoclonal IgM antibodies raised against Candida albicans Hyr1 provide cross-kingdom protection against Gram negative bacteria EG Youssef, S Alkhazraji, T Ghebremariam, L Zhang, S Singh, NY Yount, ... bioRxiv, 687442, 2019 | 1 | 2019 |
| novel Immunization Strategies Against Multi-drug-resistant Gram-negative Bacteria EA Youssef, L Lin, L Zhang, AS Ibrahim Open forum infectious diseases 4, S477, 2017 | 1 | 2017 |
| Determine the Extent and Type of Tissue Injury Caused by Mucorales in Lungs Using Pneumonia Mouse Model E Youssef, T Ghebremariam, Y Gu, S Danopoulos, D Al Alam, A Ibrahim B63. IMMUNOCOMPROMISED HOST PROBLEMS AND COMPLICATIONS, A3889-A3889, 2023 | | 2023 |
| Efficacy of an oral lipid nanocrystal (LNC) formulation of amphotericin B (MAT2203) in the neutropenic mouse model of pulmonary mucormycosis Y Gu, T Gebremariam, S Alkhazraji, E Youssef, S El-Gamal, T Matkovits, ... bioRxiv, 2023.11. 22.568278, 2023 | | 2023 |
| 1705. Filamentous Hemagglutinin Polyclonal Antibodies Protect against Multidrug resistant Gram-negative bacteria E Youssef, S Alkhazraji, S Singh, T Gebremariam, A Ibrahim Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 1335, 2022 | | 2022 |
| 97. A Cross-kingdom Vaccine Protects against Multiple Healthcare-associated Infections S Singh, AM Barbarino, E Youssef, T Ghbremariam, S Nabeela, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 175, 2022 | | 2022 |
| EVALUATION OF T- REGULATORY CELLS IN BREAST CANCER EAG Ola Sayed Mohamed Ali, Maha A. El-Taweel, Iman Attia Abdel El-Gawad International Journal of Advanced Research (IJAR) 5 (3), 99-107, 2017 | | 2017 |
Ashraf IbrahimDavid Geffen School of Medicine at UCLA; The Lundquist Institute at Harbor-UCLA Medical CenterVerified email at lundquist.org
